Project goal

  • Initial European commercial introduction starting with a 4-site seeding study in UK, Germany, France & Belgium

Metrics for success

  • Beta sites able to recruit and convert patients + long-term usage of system


  • Fifty percent of the sites have fully integrated TearScience into their practices. TearScience has now been aquired by Johnson & Johnson